Maleimido-mono-amide-DOTA-tris (t-Bu ester)

Founded in 2022 and based in Changshu, Suzhou, Jiangsu, Kangming Yongrui Biotechnology (Suzhou) Co., Ltd offers synthesis customization services for fine chemicals and intermediates, along with pharmaceutical outsourcing, custom research and consulting, and CRO contract services, selling to customers across North America, Europe, Asia, the Middle East and Africa. The company competes on an experienced R&D team, delivery speed, a rich product line, and acceptance of buyer specifications and small orders.